Skip to search.
 FTSE 100 Up 0.08%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
6.67 Up 0.13(1.99%) 27 May 21:00
Prev Close:6.54
Open:6.56
Bid:5.70 x 1000
Ask:6.89 x 100
1y Target Est:18.75
Beta:2.69849
Earnings Date:3 Aug - 8 Aug (Est.)
Day's Range:6.44 - 6.70
52wk Range:4.63 - 13.38
Volume:360,375
Avg Vol (3m):872,534
Market Cap:470.18m
P/E (ttm):N/A
EPS (ttm):-0.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SGMO at this time.

Comparison

Symbol% ChgMkt Cap
SGMOUp 1.99%470.18m
LLYDown 0.70%79.13b
AMGNUp 0.77%117.75b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.98
Quarterly EPS Est (Jun-16) :-0.24
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback